Home
Healthcare
Diagnostics & Biotech
Aptamers Market Size, Share, Growth & Industry Trends [2030]

Aptamers Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - by Types (Nucleic Acid and Peptide), Applications (Diagnostics, Therapeutics, Research and Development, and Others), and Regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

HC-774
4.1 Rating
184 Pages

Upcoming
73 Reviews

Author:

Raksha Sharma

Fact-checked by:

Vineet Pandey

Editor:

Shreyas Tandon

Report Description

The global aptamers market size is anticipated to expand at a robust CAGR during the forecast period, 2021-2028. The growth of the market is attributed to numerous advantages offered by these small molecules in comparison to established antibodies.

Aptamer is an artificial chemical antibody that is generated from the randomized nucleic acid library by three simple steps, which are binding, separation, and amplification. The selected aptamer has a high binding affinity with the target molecule. In most cases, aptamer was found to be better than other antibodies.

Aptamers are short, single-stranded DNA or RNA molecules that can selectively bind to a specific target, including proteins, peptides, carbohydrates, small molecules, toxins, and even live cells. These molecules have a variety of shapes due to their tendency to form helices and single-stranded loops. The huge number of possible tertiary structures allow aptamers to bind with high affinity through van der Waals, hydrogen bonding, and electrostatic interactions, to peptides or protein targets.

Market Trends, Drivers, Restraints, and Opportunities:

Ongoing advancement in aptamer development technologies is a prominent driver that is expected to contribute to the growth of the global aptamers market.
Increasing research and development expenditure is augment the aptamers market growth.
Lack of awareness of these technologies in middle and low-income countries can act as major restraints of the market.
Many aptamers have failed to meet the requisite safety and clinical studies. Thus, companies had to terminate their clinical investigation, which in turn, can hamper the market growth.
The outbreak of COVID-19 had negatively impacted the aptamers market. However, the market is anticipated to recover soon.
Aptamers are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. This factor can create lucrative opportunities for industry players during the forecast period.

Scope of the Report

The report on the global aptamers market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Aptamers Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Types (Nucleic Acid and Peptide) and Applications (Diagnostics, Therapeutics, Research and Development, and Others)
Regional scope	North America, Latin America, Europe, Asia Pacific and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Aptagen, LLC., Base Pair Biotechnologies, Inc., NOXXON Pharma, SomaLogic Inc., and Aptamer Group, AM Biotechnologies LLC, Aptamer Sciences Inc., Aptus Biotech S.L., TriLink BioTechnologies Inc., and Vivonics Inc.

Aptamers Market Segment Insights:

Nucleic acid segment to grow at a rapid pace
Based on types, the market is divided into nucleic acid and peptide. The nucleic acid segment is anticipated to account for a key share and is anticipated to grow at a steady rate during the forecast period. Rising research and development initiatives on DNA-based aptamers is driving the segment growth. Nucleic acid-based aptamers are chemically equivalent of antibodies and can form secondary and tertiary structures that are capable of specifically binding proteins or other cellular targets, contributing to the segment growth.

Diagnostics segment to account a major market share
Based on applications, the market is divided into diagnostics, therapeutics, research and development, and others. The diagnostics segment is anticipated to account for a major share due to rising demand of aptamers. These molecules are presently being used as a bio-recognition element in a variety of diagnostic systems in order to detect viral proteins, either in the blood or infected cells.

North America to account a considerable market share
On the basis of regions, the market is segregated into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The market in North America is anticipated to dominate the aptamers market due to rapid technological advancements and high investment and funding to support the development of aptamers. Moreover, growing acceptance of personalized medicine is aiding the market grow in the region.

Segments

Segments Covered in the Report
The global aptamers has been segmented on the basis of

Types

Nucleic Acid
Peptide

Applications

Diagnostics
Therapeutics
Research and Development
Others

Key Players

Aptagen, LLC
Base Pair Biotechnologies, Inc.
NOXXON Pharma
SomaLogic Inc.
Aptamer Group
AM Biotechnologies LLC
Aptamer Sciences Inc.
Aptus Biotech S.L.
TriLink BioTechnologies Inc.
Vivonics Inc

Competitive Landscape

The major players of the market are Aptagen, LLC., Base Pair Biotechnologies, Inc., NOXXON Pharma, SomaLogic Inc., Aptamer Group, AM Biotechnologies LLC, Aptamer Sciences Inc., Aptus Biotech S.L., TriLink BioTechnologies Inc., and Vivonics Inc.

Companies are focusing on innovation, expansion, and acquisitions to expand their market share.

Aptamers Market By Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Aptamers Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Aptamers Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Aptamers Market - Supply Chain
  4.5. Global Aptamers Market Forecast
     4.5.1. Aptamers Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Aptamers Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Aptamers Market Absolute $ Opportunity
5. Global Aptamers Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Aptamers Market Size and Volume Forecast by Types
     5.3.1. Nucleic Acid
     5.3.2. Peptide
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Aptamers Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Aptamers Market Size and Volume Forecast by Applications
     6.3.1. Diagnostics
     6.3.2. Therapeutics
     6.3.3. Research and Development
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Aptamers Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Aptamers Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Aptamers Demand Share Forecast, 2019-2026
8. North America Aptamers Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Aptamers Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Aptamers Market Size and Volume Forecast by Types
     8.4.1. Nucleic Acid
     8.4.2. Peptide
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Aptamers Market Size and Volume Forecast by Applications
     8.7.1. Diagnostics
     8.7.2. Therapeutics
     8.7.3. Research and Development
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Aptamers Demand Share Forecast, 2019-2026
9. Latin America Aptamers Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Aptamers Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Aptamers Market Size and Volume Forecast by Types
     9.4.1. Nucleic Acid
     9.4.2. Peptide
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Aptamers Market Size and Volume Forecast by Applications
     9.7.1. Diagnostics
     9.7.2. Therapeutics
     9.7.3. Research and Development
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Aptamers Demand Share Forecast, 2019-2026
10. Europe Aptamers Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Aptamers Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Aptamers Market Size and Volume Forecast by Types
     10.4.1. Nucleic Acid
     10.4.2. Peptide
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Aptamers Market Size and Volume Forecast by Applications
     10.7.1. Diagnostics
     10.7.2. Therapeutics
     10.7.3. Research and Development
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Aptamers Demand Share Forecast, 2019-2026
11. Asia Pacific Aptamers Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Aptamers Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Aptamers Market Size and Volume Forecast by Types
     11.4.1. Nucleic Acid
     11.4.2. Peptide
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Aptamers Market Size and Volume Forecast by Applications
     11.7.1. Diagnostics
     11.7.2. Therapeutics
     11.7.3. Research and Development
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Aptamers Demand Share Forecast, 2019-2026
12. Middle East & Africa Aptamers Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Aptamers Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Aptamers Market Size and Volume Forecast by Types
     12.4.1. Nucleic Acid
     12.4.2. Peptide
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Aptamers Market Size and Volume Forecast by Applications
     12.7.1. Diagnostics
     12.7.2. Therapeutics
     12.7.3. Research and Development
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Aptamers Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Aptamers Market: Market Share Analysis
  13.2. Aptamers Distributors and Customers
  13.3. Aptamers Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Aptagen, LLC
     13.4.2. Base Pair Biotechnologies, Inc.
     13.4.3. NOXXON Pharma
     13.4.4. SomaLogic Inc.
     13.4.5. Aptamer Group
     13.4.6. AM Biotechnologies LLC
     13.4.7. Aptamer Sciences Inc.
     13.4.8. Aptus Biotech S.L.
     13.4.9. TriLink BioTechnologies Inc.
     13.4.10. Vivonics Inc

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By